Bone Health & Osteonecrosis After COVID‑19: Causes, Diagnostics, Treatment & Prevention

Causes & Risk Factors- Corticosteroid use - In severe COVID‑19 with respiratory distress, corticosteroids like dexamethasone or methylprednisolone are often used. These can impair blood flow to bone tissue, leading to cell death (osteonecrosis). - Vascular and thrombotic issues - Micro‑emboli, small clots, and disturbed blood flow during or after COVID‑19 can reduce oxygen/nutrient supply to bone and contribute to osteonecrosis. - Inflammatory responses and immune dysregulation - High inflammation, elevated cytokines, strong immune responses, and disease severity all increase risk of damaging bone microstructure. - Dose and duration - Higher doses, longer steroid courses, earlier onset of symptoms, and more severe illness raise the risk. Diagnostics- Clinical assessment & symptoms - Pain, especially in hip area; limping; movement restriction; worsening with activity. - Screening - For people in risk groups (e.g. those who used steroids), periodic evaluation; MRT is the most reliable for early detection. - Radiological classification - Systems like Ficat, ARCO to define stage, presence of collapse, degree of necrosis. TreatmentStage Treatment Approach Early (Ficat I–II, no collapse) Conservative management: rest, avoid weight‑bearing, NSAIDs, Vitamin D & bone support agents; follow‑up MRT. Intermediate (Ficat II‑III, beginning collapse) Core decompression; PRP / BMAC therapies; physical therapy & rehabilitation. Late (Ficat IV, structural collapse, loss of joint function) Total joint replacement (prosthesis); bone grafting; long recovery and rehab period. Prevention- Use corticosteroids only when necessary, at minimal effective dose, shortest duration possible. - Maintain adequate Vitamin D & calcium levels; good nutrition. - Regular safe physical activity. - Periodic imaging (MRT or X‑ray) for those at risk.